Skip to main content
. 2019 Apr 3;27(5):682–693. doi: 10.1016/j.jsps.2019.04.003

Fig. 2.

Fig. 2

A. 3D alignment of compound 16 (blue) and sunitinib (green) in the active site of VEGFR2. B. 2D presentation of the interactions between compound 16 and the active site of VEGFR2. Hydrogen bonds are indicated as green dotted lines.